Cutaneous larva migrans: A case report successfully treated with albendazole

Area of Science:

• Dermatology
• Infectious Diseases
• Parasitology

Background:

• Cutaneous larva migrans (CLM) is a helminthic infection prevalent in tropical and subtropical regions.
• It results from hookworm larvae (e.g., from cats and dogs) penetrating the skin.
• CLM manifests as pruritic, erythematous, and serpiginous skin eruptions.

Observation:

• A case study involving a 45-year-old male with a characteristic 2-3 cm linear, erythematous, and serpiginous lesion on his right foot.
• Clinical presentation included significant pruritus.
• Standard blood tests and chest X-ray were performed for investigation.

Findings:

• The patient presented with a classic CLM lesion.
• Treatment with Albendazole (400mg daily for seven days) led to significant regression of the skin lesion.
• Pruritus also substantially decreased post-treatment.

Implications:

• This case highlights the clinical diagnosis of hookworm-related CLM based on characteristic skin findings.
• Awareness is crucial for clinicians, especially in patients with a history of travel to endemic areas and activities like walking barefoot.
• Albendazole is an effective treatment option for cutaneous larva migrans.